search
Back to results

Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra (HPV)

Primary Purpose

Cervical Cancer

Status
Unknown status
Phase
Not Applicable
Locations
India
Study Type
Interventional
Intervention
Education by Pamphlets
Health education programme
Sponsored by
Tata Memorial Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cervical Cancer focused on measuring Cervical Cancer and HPV infection

Eligibility Criteria

30 Years - 55 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Sexually active women in the age group of 30-55 years in the selected areas.

Exclusion Criteria:

  • Pregnant women
  • Women having frank cervical cancer
  • Women who have undergone total hysterectomy

Sites / Locations

  • Tata Memorial Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Education by Pamphlets

Health education programme

Arm Description

Half of the women in each group will be provided an information pamphlet on the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer and how to use the self samplers at home.

Half of the women in each group will be invited to specially organised camps in their neighbourhood for Health Education and distribution of self samplers.

Outcomes

Primary Outcome Measures

Agreement rate between health care personnel collected samples and self collected samples in these two groups.
Results obtained out of the health care personnel collected samples Vs self collected samples and correspondingly results of the test among women taught to use self samplers with the aid of pamphlets as compared to a well conducted health education programme will be evaluated using kappa statistics.

Secondary Outcome Measures

Test characteristics of HPV self sample and health care worker collected sample by HPV HC 2.
sensitivity, specificity, positive predictive value, negative predictive value, false positive rate and false negative rate will be calculated for self collected HPV samples and health personnel collected HPV samples
Acceptability and barriers for self-collection of specimens for HPV DNA testing in an urban population.
The acceptability and barriers for self collection of specimens for HPV DNA test will be calculated by using multiple logistic regression analysis for various socio-demographic and risk factors and my recording of reasons for the same

Full Information

First Posted
April 18, 2017
Last Updated
August 3, 2018
Sponsor
Tata Memorial Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT03386695
Brief Title
Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra
Acronym
HPV
Official Title
Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra
Study Type
Interventional

2. Study Status

Record Verification Date
August 2018
Overall Recruitment Status
Unknown status
Study Start Date
September 2018 (Anticipated)
Primary Completion Date
January 2019 (Anticipated)
Study Completion Date
January 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tata Memorial Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The study goals are, To determine the test characteristics (sensitivity, specificity, positive predictive value, negative predictive value, false positivity rates, false negativity rates) of health personnel collected and self collected HPV samples for Hybrid capture explained by two different methods (pamphlets/ health education programme). To evaluate the agreement between self collected HPV samples and health personnel collected HPV samples for Hybrid capture with two different methods of education (pamphlets/ health education programme). To study the attitudes, acceptability and barriers of self-collection of specimens for HPV DNA testing in three sub groups of population in Maharashtra with two different methods of education (pamphlets/ health education programme). To determine the predictors of self-sampling preference. To determine the Knowledge, Attitudes and Practices (KAP) regarding cervical cancer and HPV infection among these women in pre-intervention and post-intervention period.
Detailed Description
The three communities, urban slum area in Mumbai, urban non slum area in Mumbai and rural area in Raigad/ Thane district will be selected. The eligible women will be contacted by door to door visit and the purpose of the campaign will be explained to them. Informed consent will be obtained from those who are willing to participate in the study. Step 1: They will be interviewed to collect the baseline Knowledge, Attitude and Practices (KAP) regarding cervical cancer, screening and HPV. The information will be recorded on a structured questionnaire. Step 2: Half of the women in each group will be invited to specially organized camps in their neighborhood for Health Education and distribution of self samplers while the other half will be provided an information pamphlet on the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer and how to use the self samplers at home. Similar personal interviews, collection of used/unused self sampler and collection of HPV samples by health worker will be followed for both groups of women. Intervention one: (Health Education Group) Detailed health education programme explaining them the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer will be conducted. They will be explained the importance of getting screened for cervical cancer and will be encouraged to undergo screening at any nearby screening centre. They will be given information regarding HPV self samplers and will be taught the method of its use and storage in detail. Any queries with this regard will be answered. Intervention two: (Both Groups) HPV self samplers will be distributed free of cost to the women and the social workers will instruct them to return it to the clinic or will collect the samplers from their houses, either on the same day or the following day as per the convenience of the woman. For HPV self collection the participating women will be asked to collect the sample specimen as per instructions provided during the health education session/ pamphlets and store it at room temperature till the time of collection by the social worker. The willingness to use self sampler or refusal to use the HPV self sampler will be captured. Also, the reasons for their refusal shall be captured. Step 3: (Both Groups) During the visit by social worker to collect the samples, the women will be again interviewed by the social worker for their experience about collecting the sample at home. Personal interviews will be conducted also to assess their acceptability of self sampling for HPV detection. Various queries regarding difficulties in obtaining, storing and transporting the samples as well as other potential factors likely to affect the acceptability of the self sampling methods will be assessed. Any injuries, barriers and motivators for self sampling will be recorded. The women who refuse to use self samplers at this stage will also be interviewed to understand the barriers. HPV sample will be collected by the health worker when the woman comes to return the sampler kit. It will also be collected for women who refuse self sampling but are ready for health worker collected sample. Information about the post-intervention KAP regarding cervical cancer, screening and HPV will be again recorded on a structured questionnaire from all women. Step 4: (Both Groups) HPV testing will be performed with the Hybrid Capture System II {Digene}, which detects 13 different high-risk HPV types {16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68}. The test will run according to the manufacturer's protocol. HPV determination will be quantitative, and women with samples producing readings of one or more times the positive control (1pg/ml HPV DNA) will be considered as HPV test positive. Step 5: (Both Groups) The reports of self sampling HPV will be distributed to the women after 15 days. The women who test positive on either test will be contacted personally by staff or by telephone and will be offered free Preventive Oncology check up, Colposcopy and necessary work up either at Tata Memorial Hospital. The women not willing to avail facility at TMH will be referred to the nearby municipal or private hospital offering these services. The women who are positive or negative on colposcopy will undergo further diagnosis and management as per departmental service protocol. The health worker will co-ordinate between the field staff and the various departments at TMH. The health worker will submit the samples to the department of Microbiology at the TMH, will collect the reports and send it to the field social workers for distribution, will assist the HPV positive patients for further investigations and diagnosis at the TMH.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Cancer
Keywords
Cervical Cancer and HPV infection

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Non-Randomized
Enrollment
1600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Education by Pamphlets
Arm Type
Other
Arm Description
Half of the women in each group will be provided an information pamphlet on the risk factors, methods of early detection, prevention, signs and symptoms of cervical cancer and how to use the self samplers at home.
Arm Title
Health education programme
Arm Type
Other
Arm Description
Half of the women in each group will be invited to specially organised camps in their neighbourhood for Health Education and distribution of self samplers.
Intervention Type
Other
Intervention Name(s)
Education by Pamphlets
Intervention Description
Distribution of pamphlets with information of prevention and early detection of cervical cancer and written as well as pictorial depiction on how to collect cervical self sample for HPV detection.
Intervention Type
Other
Intervention Name(s)
Health education programme
Intervention Description
Health education program explaining about prevention and early detection of cancer and education on method of collection of cervical self sample for HPV.
Primary Outcome Measure Information:
Title
Agreement rate between health care personnel collected samples and self collected samples in these two groups.
Description
Results obtained out of the health care personnel collected samples Vs self collected samples and correspondingly results of the test among women taught to use self samplers with the aid of pamphlets as compared to a well conducted health education programme will be evaluated using kappa statistics.
Time Frame
18 months
Secondary Outcome Measure Information:
Title
Test characteristics of HPV self sample and health care worker collected sample by HPV HC 2.
Description
sensitivity, specificity, positive predictive value, negative predictive value, false positive rate and false negative rate will be calculated for self collected HPV samples and health personnel collected HPV samples
Time Frame
18 months
Title
Acceptability and barriers for self-collection of specimens for HPV DNA testing in an urban population.
Description
The acceptability and barriers for self collection of specimens for HPV DNA test will be calculated by using multiple logistic regression analysis for various socio-demographic and risk factors and my recording of reasons for the same
Time Frame
18 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Sexually active women in the age group of 30-55 years in the selected areas. Exclusion Criteria: Pregnant women Women having frank cervical cancer Women who have undergone total hysterectomy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gauravi A Mishra, M.D PSM
Phone
+912224177000
Ext
4634
Email
gauravi2005@yahoo.co.in
First Name & Middle Initial & Last Name or Official Title & Degree
Sharmila A Pimple, M.D PSM
Phone
+912224154379
Email
drsharmilapatil@yahoo.co.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gauravi A Mishra, MD
Organizational Affiliation
Tata Memorial Hospital, Mumbai
Official's Role
Principal Investigator
Facility Information:
Facility Name
Tata Memorial Hospital
City
Mumbai
State/Province
Maharashtra
ZIP/Postal Code
400012
Country
India
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dr. Gauravi A Mishra, M.D PSM
Phone
+912224177000
Ext
4634
Email
gauravi2005@yahoo.co.in
First Name & Middle Initial & Last Name & Degree
Dr. gauravi A Mishra, M.D PSM

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra

We'll reach out to this number within 24 hrs